Salvianolic acid A attenuates ischemia reperfusion induced rat brain damage by protecting the blood brain barrier through MMP-9 inhibition and anti-inflammation

Ovbiagele, 2011, Stroke epidemiology: advancing our understanding of disease mechanism and therapy [J], Neurotherapeutics, 8, 319, 10.1007/s13311-011-0053-1 Wardlaw, 2012, Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis [J], Lancet, 379, 2364, 10.1016/S0140-6736(12)60738-7 Adeoye, 2011, Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States a doubling of treatment rates over the course of 5 years [J], Stroke, 42, 1952, 10.1161/STROKEAHA.110.612358 Fonarow, 2011, Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes [J], Circulation, 123, 750, 10.1161/CIRCULATIONAHA.110.974675 Lee, 2012, Blood–brain barrier permeability derangements in posterior circulation ischemic stroke: frequency and relation to hemorrhagic transformation [J], J Neurol Sci, 313, 142, 10.1016/j.jns.2011.08.048 Rempe, 2016, Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers [J], J Cereb Blood Flow Metab, 36, 1481, 10.1177/0271678X16655551 Chaturvedi, 2014, MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke [J], Mol Neurobiol, 49, 563, 10.1007/s12035-013-8538-z Yang, 2015, Matrix metalloproteinases as therapeutic targets for stroke [J], Brain Res, 1623, 30, 10.1016/j.brainres.2015.04.024 Khokha, 2013, Metalloproteinases and their natural inhibitors in inflammation and immunity [J], Nat Rev Immunol, 13, 649, 10.1038/nri3499 Du, 1995, Protective effects of salvianolic acid A against impairment of memory induced by cerebral ischemia-reperfusion in mice [J], Acta Pharm Sin, 30, 184 Du, 1997, Protective effects of salvianolic acid A against impairment of memory induced by cerebral ischemia-reperfusion in mice [J], Chin Med J, 110, 65 Jiang, 2008, Effect of salvianolic acid A in CD11b/CD18 expression in focal brain ischemia-reperfusion [J], Liaoning J Tradit Chin Med, 35, 1425 Jiang, 2008, Effect of salvianolic acid A on ICAM-1 expression after Hypoxia/Reoxygenation injury in brain microvascular endothelial cells [J], Tianjin J Tradit Chin Med, 25, 406 Jiang, 2009, Effect of salvianolic acid A in ICAM-1 expression in focal brain ischemia-reperfusion [J], Liaoning J Tradit Chin Med, 36, 469 Wang, 2012, Protection of salvianolic acid A on rat brain from ischemic damage via soluble epoxide hydrolase inhibition [J], J Asian Nat Prod Res, 14, 1084, 10.1080/10286020.2012.723200 Shang, 2007, Protective effects of salvianolic acid A on focal cerebral ischemia in rats [J], Pharmacol Clin Chin Mater Med, 23, 15 Jiang, 2011, Cerebral protection of salvianolic acid A by the inhibition of granulocyte adherence [J], Am J Chin Med, 39, 111, 10.1142/S0192415X11008683 Lin, 2007, Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells [J], J Cell Biochem, 100, 372, 10.1002/jcb.21042 Chien, 2016, Salvianolic acid A alleviates ischemic brain injury through the inhibition of inflammation and apoptosis and the promotion of neurogenesis in mice [J], Free Radic Biol Med, 99, 508, 10.1016/j.freeradbiomed.2016.09.006 Jiang, 2013, Salvianolic acid A, a novel matrix metalloproteinase-9 inhibitor, prevents cardiac remodeling in spontaneously hypertensive rats [J], PLoS One, 8, e59621, 10.1371/journal.pone.0059621 Zhang, 2014, Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice [J], Phytomedicine, 21, 1137, 10.1016/j.phymed.2014.05.003 Song, 2015, Pharmacokinetics of salvianolic acid A after single intravenous administration in Rhesus monkey [J], Acta Pharm Sin, 50, 1142 Sun, 2013, Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality [J], J Ethnopharmacol, 148, 617, 10.1016/j.jep.2013.05.013 Pei, 2008, A sensitive method for determination of salvianolic acid A in rat plasma using liquid chromatography/tandem mass spectrometry [J], Biomed Chromatogr, 22, 786, 10.1002/bmc.1043 Mhairi, 1992, New models of focal cerebral ischaemia [J], Br J Clin Pharmacol, 34, 302, 10.1111/j.1365-2125.1992.tb05634.x Longa, 1989, Reversible middle cerebral artery occlusion without craniectomy in rats [J], Stroke, 20, 84, 10.1161/01.STR.20.1.84 Longa, 1989, Reversible middle cerebral artery occlusion without craniectomy in rats [J], Stroke, 20, 84, 10.1161/01.STR.20.1.84 Clark, 1997, Monofilament intraluminal middle cerebral artery occlusion in the mouse [J], Neurol Res, 19, 641, 10.1080/01616412.1997.11740874 Mdzinarishvili, 2007, Bilobalide prevents ischemia-induced edema formation in vitro and in vivo [J], Neuroscience, 144, 217, 10.1016/j.neuroscience.2006.08.037 Yuan, 2017, Salvianolic acid A protects against myocardial ischemia/reperfusion injury by reducing platelet activation and inflammation [J], Exp Ther Med, 14, 961, 10.3892/etm.2017.4619 Mahmood, 2017, Salvianolic acid A inhibits calpain activation and eNOS uncoupling during focal cerebral ischemia in mice [J], Phytomedicine, 25, 8, 10.1016/j.phymed.2016.12.004 Teng, 2016, Salvianolic acid A inhibits endothelial dysfunction and vascular remodeling in spontaneously hypertensive rats [J], Life Sci, 144, 86, 10.1016/j.lfs.2015.06.010 Xu, 2014, The anti-apoptotic and cardioprotective effects of salvianolic acid A on rat cardiomyocytes following ischemia/reperfusion by DUSP-mediated regulation of the ERK1/2/JNK pathway [J], PLoS One, 9, e102292, 10.1371/journal.pone.0102292 Sandoval, 2008, Blood-brain barrier tight junction permeability and ischemic stroke [J], Neurobiol Dis, 32, 200, 10.1016/j.nbd.2008.08.005 Yang, 2011, Blood–brain barrier breakdown in acute and chronic cerebrovascular disease [J], Stroke, 42, 3323, 10.1161/STROKEAHA.110.608257 Hu, 2007, Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases [J], Nat Rev Drug Discov, 6, 480, 10.1038/nrd2308 Chaturvedi, 2014, MMP-9 inhibition: a therapeutic strategy in ischemic stroke [J], Mol Neurobiol, 49, 563, 10.1007/s12035-013-8538-z Yabluchanskiy, 2013, Matrix metalloproteinase-9: many shades of function in cardiovascular disease [J], Physiology, 28, 391, 10.1152/physiol.00029.2013 Abbott, 2010, Structure and function of the blood–brain barrier [J], Neurobiol Dis, 37, 13, 10.1016/j.nbd.2009.07.030 Jiao, 2011, Specific role of tight junction proteins Claudin-5, Occludin, and ZO-1 of the blood–brain barrier in a focal cerebral ischemic insult [J], J Mol Neurosci, 44, 130, 10.1007/s12031-011-9496-4 Parks, 2004, Matrix metalloproteinases as modulators of inflammation and innate immunity [J], Nat Rev Immunol, 4, 617, 10.1038/nri1418 Oh, 2011, Salvianolic acid A suppress lipopolysaccharide-induced NF-κB signaling pathway by targeting IKKβ [J], Int Immunopharmacol, 11, 1901, 10.1016/j.intimp.2011.07.022 Huang, 2013, In silico analysis and experimental validation of molecular mechanisms of salvianolic acid A-inhibited LPS-stimulated inflammation, in RAW264.7 macrophages [J], Cell Prolif, 46, 595 Wang, 2010, Anti-inflammatory activity of salvianolic acid B in microglia contributes to its neuroprotective effect [J], Neurochem Res, 35, 1029, 10.1007/s11064-010-0151-1 Tang, 2006, Salvianolic acid B improves motor function after cerebral ischemia in rats [J], Behav Pharmacol, 17, 493, 10.1097/00008877-200609000-00015 Zhao, 2008, Influence of salvianolic acid B on serum SOD activities and MDA concentrations in rats with focal cerebral ischemia-reperfusion [J], Tianjin J Tradit Chin Med, 25, 63